Memory persistence is a dynamic process involving the reconsolidation of memories after their reactivation. Reconsolidation impairments have been demonstrated for many types of memories in rats, and signaling at N-methyl-D-aspartate (NMDA) receptors appears often to be a critical pharmacological mechanism. Here we investigated the reconsolidation of appetitive pavlovian memories reinforced by natural rewards. In male Lister Hooded rats, systemic administration of the NMDA receptor antagonist (+)-5-methyl-10,11-dihydro-SH-dibenzo{a,d}cyclohepten-5,10-imine maleate (MK-801, 0.1 mg/kg i.p.) either before or immediately following a brief memory reactivation session abolished the subsequent acquisition of a new instrumental response with sucrose conditioned reinforcement. However, only when injected prior to memory reactivation was MK-801 effective in disrupting the maintenance of a previously-acquired instrumental response with conditioned reinforcement. These results demonstrate that NMDA receptor-mediated signaling is required for appetitive pavlovian memory reconsolidation.
Introduction
Reconsolidation refers to the process that is disrupted when amnesia for an old memory is effected in a manner critically dependent upon the reactivation of that memory at the time of amnestic treatment (Lewis, Bregman, & Mahan, 1972; Nader, 2003) . Such reactivation-dependent amnesia was initially demonstrated in rats using electroconvulsive shock treatment (Misanin, Miller, & Lewis, 1968; Schneider & Sherman, 1968) , and has since been described in a wide variety of memory systems across a number of species (Child, Epstein, Kuzirian, & Alkon, 2003; Eisenberg & Dudai, 2004; Litvin & Anokhin, 2000; Pedreira, Perez-Cuesta, & Maldonado, 2002; Rose & Rankin, 2006; Sangha, Scheibenstock, & Lukowiak, 2003; Stollhoff, Menzel, & Eisenhardt, 2005; Suzuki et al., 2004) , including humans (Forcato et al., 2007; Hupbach, Gomez, Hardt, & Nadel, 2007; Walker, Brakefield, Hobson, & Stickgold, 2003) .
Beginning with the demonstration that the reconsolidation of conditioned fear memories in rats relies upon de novo protein synthesis in the basolateral amygdala (BLA) (Nader, Schafe, & Le Doux, 2000) , the neural substrates of reconsolidation of many types of memories in rodents have been elucidated (Akirav & Maroun, 2006; Debiec, LeDoux, & Nader, 2002; Eisenberg, Kobilo, Berman, & Dudai, 2003; Kelly, Laroche, & Davis, 2003; Lee, Everitt, & Thomas, 2004; Morris et al., 2006; Wang, Ostlund, Nader, & Balleine, 2005) , though reactivation-dependent amnesia remains to be observed in certain experimental paradigms (Biedenkapp & Rudy, 2004; Hernandez & Kelley, 2004) . While the study of fear memory reconsolidation may point to potential treatments for post-traumatic stress disorder (Debiec & LeDoux, 2006) , much attention has now turned to impairing drug memory reconsolidation as 
